Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Other financing activities (2025)

InflaRx's Other financing activities history spans 1 years, with the latest figure at $13.6 million for Q1 2025.

  • On a quarterly basis, Other financing activities changed N/A to $13.6 million in Q1 2025 year-over-year; TTM through Dec 2025 was $13.6 million, a N/A change, with the full-year FY2025 number at $15.0 million, changed N/A from a year prior.
  • Other financing activities hit $13.6 million in Q1 2025 for InflaRx.
  • Over the last five years, Other financing activities for IFRX hit a ceiling of $13.6 million in Q1 2025 and a floor of $13.6 million in Q1 2025.